887 related articles for article (PubMed ID: 18437149)
1. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
Mozaffari MS; Schaffer SW
Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
[TBL] [Abstract][Full Text] [Related]
2. Roles of phospho-GSK-3β in myocardial protection afforded by activation of the mitochondrial K ATP channel.
Terashima Y; Sato T; Yano T; Maas O; Itoh T; Miki T; Tanno M; Kuno A; Shimamoto K; Miura T
J Mol Cell Cardiol; 2010 Nov; 49(5):762-70. PubMed ID: 20692265
[TBL] [Abstract][Full Text] [Related]
3. GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion.
Gross ER; Hsu AK; Gross GJ
Basic Res Cardiol; 2007 Jul; 102(4):341-9. PubMed ID: 17450314
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.
Obame FN; Plin-Mercier C; Assaly R; Zini R; Dubois-Randé JL; Berdeaux A; Morin D
J Pharmacol Exp Ther; 2008 Jul; 326(1):252-8. PubMed ID: 18434587
[TBL] [Abstract][Full Text] [Related]
5. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
[TBL] [Abstract][Full Text] [Related]
6. Cardioprotection by GSK-3 inhibition: role of enhanced glycogen synthesis and attenuation of calcium overload.
Omar MA; Wang L; Clanachan AS
Cardiovasc Res; 2010 Jun; 86(3):478-86. PubMed ID: 20053658
[TBL] [Abstract][Full Text] [Related]
7. Protection of ischaemic-reperfused rat heart by dimethylamiloride is associated with inhibition of mitochondrial permeability transition.
Prendes MG; Torresín E; González M; Fernández MA; Perazzo JC; Savino EA; Varela A
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):201-6. PubMed ID: 17941897
[TBL] [Abstract][Full Text] [Related]
8. Local delivery of PKCepsilon-activating peptide mimics ischemic preconditioning in aged hearts through GSK-3beta but not F1-ATPase inactivation.
Korzick DH; Kostyak JC; Hunter JC; Saupe KW
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2056-63. PubMed ID: 17675573
[TBL] [Abstract][Full Text] [Related]
9. Pressure overload regulates expression of cytokines, γH2AX, and growth arrest- and DNA-damage inducible protein 153 via glycogen synthase kinase-3β in ischemic-reperfused hearts.
Baban B; Liu JY; Mozaffari MS
Hypertension; 2013 Jan; 61(1):95-104. PubMed ID: 23108649
[TBL] [Abstract][Full Text] [Related]
10. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B
Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250
[TBL] [Abstract][Full Text] [Related]
11. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta.
Park SS; Zhao H; Jang Y; Mueller RA; Xu Z
J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation.
Das S; Wong R; Rajapakse N; Murphy E; Steenbergen C
Circ Res; 2008 Oct; 103(9):983-91. PubMed ID: 18802025
[TBL] [Abstract][Full Text] [Related]
13. Sevoflurane enhances ethanol-induced cardiac preconditioning through modulation of protein kinase C, mitochondrial KATP channels, and nitric oxide synthase, in guinea pig hearts.
Kaneda K; Miyamae M; Sugioka S; Okusa C; Inamura Y; Domae N; Kotani J; Figueredo VM
Anesth Analg; 2008 Jan; 106(1):9-16, table of contents. PubMed ID: 18165545
[TBL] [Abstract][Full Text] [Related]
14. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.
Onishi A; Miyamae M; Kaneda K; Kotani J; Figueredo VM
Eur J Pharmacol; 2012 Jan; 675(1-3):40-6. PubMed ID: 22166375
[TBL] [Abstract][Full Text] [Related]
15. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
Hausenloy DJ; Maddock HL; Baxter GF; Yellon DM
Cardiovasc Res; 2002 Aug; 55(3):534-43. PubMed ID: 12160950
[TBL] [Abstract][Full Text] [Related]
17. The mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha.
Gao Q; Zhang SZ; Cao CM; Bruce IC; Xia Q
Cytokine; 2005 Dec; 32(5):199-205. PubMed ID: 16260145
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
[TBL] [Abstract][Full Text] [Related]
19. K(ATP) channels and MPTP are involved in the cardioprotection bestowed by chronic intermittent hypobaric hypoxia in the developing rat.
Bu HM; Yang CY; Wang ML; Ma HJ; Sun H; Zhang Y
J Physiol Sci; 2015 Jul; 65(4):367-76. PubMed ID: 25862574
[TBL] [Abstract][Full Text] [Related]
20. Delayed cardioprotection afforded by the glycogen synthase kinase 3 inhibitor SB-216763 occurs via a KATP- and MPTP-dependent mechanism at reperfusion.
Gross ER; Hsu AK; Gross GJ
Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1497-500. PubMed ID: 18223186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
